We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

YM BioSciences Enrolls First US Patient in Phase II Brain Metastases Trial for Nimotuzumab

News   May 28, 2010

 
YM BioSciences Enrolls First US Patient in Phase II Brain Metastases Trial for Nimotuzumab
 
 
Advertisement
 

RELATED ARTICLES

New Cancer Vaccine Ready for Human Trials

News

A new cancer vaccine, comprised of human antibodies fused with tumor-specific protein, is ready to begin human testing.

READ MORE

Metabolomics Meets Genomics To Improve Patient Diagnosis

News

Researchers from Baylor College of Medicine have integrated whole-exome sequencing and targeted metabolomics to analyze the data of a group of 170 patients. They were pleased to find that the metabolomics data informed 44 percent of the cases.

READ MORE

Women’s Egg Quality Dependent on Metabolic Factors

News

Increasing the levels of a chemical found in all human cells could boost a woman's fertility and help select the best eggs for IVF, according to University of Queensland research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE